EuBiologics Co Ltd
KOSDAQ:206650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
VMware Inc
XETRA:BZF1
|
US |
|
S
|
Sichuan Qiaoyuan Gas Co Ltd
SZSE:301286
|
CN |
|
Z
|
Zhejiang Anglikang Pharmaceutical Co Ltd
SZSE:002940
|
CN |
|
Dalmia Bharat Sugar and Industries Ltd
NSE:DALMIASUG
|
IN |
|
Yes Optoelectronics Group Co Ltd
SZSE:002952
|
CN |
|
Quirin Privatbank AG
XETRA:QB7
|
DE |
|
Vontron Technology Co Ltd
SZSE:000920
|
CN |
EuBiologics Co Ltd
Total Current Assets
EuBiologics Co Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
EuBiologics Co Ltd
KOSDAQ:206650
|
Total Current Assets
₩137B
|
CAGR 3-Years
49%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Total Current Assets
₩6.2T
|
CAGR 3-Years
28%
|
CAGR 5-Years
20%
|
CAGR 10-Years
19%
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Total Current Assets
₩56.5B
|
CAGR 3-Years
45%
|
CAGR 5-Years
102%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Total Current Assets
₩480.8B
|
CAGR 3-Years
49%
|
CAGR 5-Years
28%
|
CAGR 10-Years
34%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Total Current Assets
₩176.1B
|
CAGR 3-Years
30%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Total Current Assets
₩39.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EuBiologics Co Ltd
Glance View
EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 323 full-time employees. The company went IPO on 2017-01-24. The firm operates its business through two segments. The Vaccine segment manufactures and sells oral cholera vaccines. The Contract Research and Manufacturing Organization (CRMO) segment contracts, researches and manufactures biopharmaceuticals.
See Also
What is EuBiologics Co Ltd's Total Current Assets?
Total Current Assets
137B
KRW
Based on the financial report for Dec 31, 2025, EuBiologics Co Ltd's Total Current Assets amounts to 137B KRW.
What is EuBiologics Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
14%
Over the last year, the Total Current Assets growth was 65%. The average annual Total Current Assets growth rates for EuBiologics Co Ltd have been 49% over the past three years , 14% over the past five years .
